Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

AbbVie Inc (ABBV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AbbVie's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
164.66 +0.41    +0.25%
18/04 - Closed. Currency in USD ( Disclaimer )
After Hours
164.99
+0.33
+0.20%
19:46:55 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 4,479,202
  • Bid/Ask: 162.92 / 167.90
  • Day's Range: 164.43 - 167.44
AbbVie 164.66 +0.41 +0.25%

NYSE:ABBV Financials

 
A brief overview of the NYSE:ABBV financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of AbbVie over time.

AbbVie Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 14,301 million compared to USD 15,121 million a year ago. Net income was USD 822 million compared to USD 2,473 million a year ago. Diluted earnings per share from continuing operations was USD 0.46 compared to USD 1.38 a year ago.For the full year, sales was USD 54,318 million compared to USD 58,054 million a year ago. Net income was USD 4,863 million compared to USD 11,836 million a year ago. Diluted earnings per share from continuing operations was USD 2.72 compared to USD 6.63 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ABBV Income Statement

Gross margin TTM 69.21%
Operating margin TTM 32.51%
Net Profit margin TTM 8.95%
Return on Investment TTM 20.1%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 14301 13927 13865 12225
Gross Profit 10026 7462 9657 8253
Operating Income 4549 2473 4772 3042
Net Income 822 1778 2024 239

ABBV Balance Sheet

Quick Ratio MRQ 0.63
Current Ratio MRQ 0.87
LT Debt to Equity MRQ 506.37%
Total Debt to Equity MRQ 584.74%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 134711 136221 135367 134544
Total Liabilities 124314 124092 122469 121241
Total Equity 10397 12129 13303 13303

ABBV Cash Flow Statement

Cash Flow/Share TTM 12.94
Revenue/Share TTM 30.77
Operating Cash Flow  12.56%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 4753 7574 6319 4193
Cash From Investing Activities -800 -369 -341 -499
Cash From Financing Activities -4449 -2661 -3920 -6192
Net Change in Cash -473 4528 2048 -2490
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABBV Comments

Write your thoughts about AbbVie Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bryan Shipley
Bryan Shipley 14 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice right? 💰 🤑
Bryan Shipley
Bryan Shipley Apr 16, 2024 9:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MoneyFlow went negative for ABBV on March 15th. The manipulated S&P didn't go negative until March 25th. ABBV MoneyFlow went positive yesterday. Let's see where this goes next.
Bryan Shipley
Bryan Shipley Mar 19, 2024 10:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
And the final blow... the 5 dma is now below the 12 dma, time for a much bigger fall 😱
Bryan Shipley
Bryan Shipley Mar 15, 2024 11:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
And NOW you see what happens after MoneyFlow and FullSto have crossed negative
Bryan Shipley
Bryan Shipley Mar 14, 2024 9:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
169, I'm ready 💪
Ron West
Ron West Dec 28, 2023 8:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold on, 2024 looks positive.
Bryan Shipley
Bryan Shipley Dec 11, 2023 8:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Beginning to become overbought, when FULL STO turns negative it will be time to take some profits IMHO
Ron West
Ron West Dec 11, 2023 8:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
maybe not yet!
Ron West
Ron West Dec 11, 2023 8:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hope you stayed in!
Nilesh Khupase
Nilesh Khupase Aug 08, 2023 3:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Best divident and growth stock ever
Nilesh Khupase
Nilesh Khupase Aug 08, 2023 3:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
# Dividend
Ron West
Ron West Aug 08, 2023 3:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
still is.
Ron West
Ron West Apr 17, 2023 9:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy
John Zeman
John Zeman Apr 17, 2023 9:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lmao
Ron West
Ron West Apr 17, 2023 9:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tom Investor
Tom Investor Jan 20, 2023 4:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
jbjhjb
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email